NCT03292588: A reported trial by National Institute of Allergy and Infectious Diseases (NIAID)
This trial has reported on time, in line with the regulations.
Full data
| Full entry on ClinicalTrials.gov | NCT03292588 |
|---|---|
| Title | Mechanisms Underlying Asthma Exacerbations Prevented and Persistent With Immune-Based Therapy: A Systems Approach Phase 2 (ICAC-30) |
| Results Status | Reported |
| ACT or pACT? | This is what FDAAA officially calls an "Applicable Clinical Trial" |
| Start date | Nov. 7, 2017 |
| Completion date | April 20, 2021 |
| Required reporting date | April 20, 2022, midnight |
| Actual reporting date | April 20, 2022 |
| Date last checked at ClinicalTrials.gov | March 28, 2025 |
| Days late | None |